Events
Impressions, recaps, and regulatory signal from the conferences, panels, and working groups where we show our work — plus where to find us next.
WHERE TO FIND US NEXT?
CVI 2026
6-8 August — Denver, Colorado
- designed to meet the needs of cardiologists, surgeons, internists, and other staff who participate in the care of patients with coronary, peripheral, and structural cardiovascular diseases
- focus of the conference is on innovative health care solutions for these patients
Events, conferences, webinars, podcasts
2026
CONFERENCE
New York Valves
24-26 June, New York
The Future of Structural Heart Care
Over the past few years, New York Valves, organized by Cardiovascular Research Foundation, has established itself as one of the leading conferences focused on structural heart disease and heart valve therapies. It brings together interventional cardiologists, cardiac surgeons, imaging specialists, researchers, and industry innovators to discuss the latest advances in diagnosis, treatment, and device technology.
New York Valves 2026 once again demonstrated why it has become one of the leading meetings in structural heart disease.
Over three days, the cardiovascular community gathered in New York to discuss the latest developments in heart valve therapies, imaging, and device innovation. The program featured late-breaking clinical data, live cases, FDA sessions, and hands-on workshops, highlighting the rapid pace of change in the field.
One theme stood out across many sessions: structural heart care is becoming increasingly personalized. Discussions focused not only on long-term outcomes for transcatheter therapies, but also on how to select the right treatment for the right patient at the right time.
For Virtonomy, it was encouraging to see how naturally topics such as simulation, digital patient twins, and computational modeling fit into these conversations. As devices become more advanced, so do the tools needed to develop and evaluate them. We are already looking forward to next year’s event.
CONFERENCE
CSI Congress
3-6 June, Frankfurt
Emphasis on Real-World Technologies
CSI Frankfurt 2026 once again brought together the global cardiovascular community for four days of lectures, live cases, hands-on training, and discussions on the latest advances in congenital, structural, and valvular heart disease.
A recurring theme throughout the conference was the increasing complexity and personalization of cardiovascular interventions. As devices and therapies continue to evolve, so does the need for technologies that support their development, evaluation, and clinical adoption. This is where our product v-Patients comes in and offers solutions with digital twins, computer modeling (medical simulations) and combines in silico methods with traditional testing.
CONFERENCE
EuroPCR
19-22 May, Paris
From Innovation to Implementation
EuroPCR has always been one of our favorite conferences in the cardiovascular space because it brings together clinicians, engineers, researchers, startups, regulators, and medical device companies all in one place. The conversations are practical, open, and focused on solving real problems in cardiovascular care.
EuroPCR 2026 highlighted a clear shift in cardiovascular innovation. While AI, simulation, and digital technologies were once emerging topics, the conversation has now moved toward practical implementation. Across sessions on structural heart interventions, imaging, and next-generation devices, attendees focused on how new technologies can be integrated into clinical and development workflows.
The conference’s emphasis on education, hands-on learning, and collaboration reinforced why EuroPCR remains one of the most influential events in interventional cardiology. For Virtonomy, it was particularly encouraging to see digital patient twins and in-silico methods increasingly recognized as part of the future of cardiovascular device development.
CONFERENCE
CX Symposium
21-23 April, London
The leading global vascular and endovascular symposium
4,000+ specialists, three days of clinical debate, and many interesting talks on the current state and the future of vascular disease management. We were there talking to device developers and cardiovascular specialists about virtual device testing for vascular applications.
Meet us in person
If you’re at one of the events above, or want to compare notes on in-silico regulatory strategy, we’d like to grab 20 minutes.